Validation of cytoplasmic-to-nuclear ratio of survivin as an indicator of improved prognosis in breast cancer. [electronic resource]
Producer: 20110331Description: 639 p. digitalISSN:- 1471-2407
- Adult
- Aged
- Aged, 80 and over
- Algorithms
- Biomarkers, Tumor -- analysis
- Breast Neoplasms -- chemistry
- Cell Nucleus -- chemistry
- Chi-Square Distribution
- Cytoplasm -- chemistry
- Decision Trees
- Estrogen Receptor Modulators -- therapeutic use
- Female
- Humans
- Image Interpretation, Computer-Assisted
- Immunohistochemistry
- Inhibitor of Apoptosis Proteins
- Kaplan-Meier Estimate
- Ki-67 Antigen -- analysis
- Microtubule-Associated Proteins -- analysis
- Middle Aged
- Pattern Recognition, Automated
- Predictive Value of Tests
- Proportional Hazards Models
- Receptor, ErbB-2 -- analysis
- Receptors, Estrogen -- analysis
- Receptors, Progesterone -- analysis
- Reproducibility of Results
- Risk Assessment
- Risk Factors
- Survivin
- Sweden
- Tamoxifen -- therapeutic use
- Time Factors
- Tissue Array Analysis
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Validation Study
There are no comments on this title.
Log in to your account to post a comment.